Article info

Download PDFPDF

Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study

Authors

  1. Correspondence to Dr Kyle Smoot; kyle.smoot{at}providence.org
View Full Text

Citation

Smoot K, Chen C, Stuchiner T, et al
Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study

Publication history

  • Received October 16, 2020
  • Accepted May 27, 2021
  • First published July 7, 2021.
Online issue publication 
July 07, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.